|
2020
|
Invention
|
Mutant kras inhibitors. Compositions and methods for inhibits the binding of GTP to oncogenic mut... |
|
2019
|
Invention
|
Amino acid depletion agents as antiproliferative agents. Novel compounds are described which decr... |
|
|
Invention
|
Neurite outgrowth promoters and uses thereof. Provided herein are compounds useful in treating a ... |
|
2018
|
Invention
|
Compositions, methods of use, and methods of treatment.
The present disclosure provides composit... |
|
|
Invention
|
Compositions, methods of use, and methods of treatment. The present disclosure provides compositi... |
|
2017
|
Invention
|
Methods for treating melanoma using small molecules. The invention provides methods for treating ... |
|
|
Invention
|
Bis-cyclic guanidine compound compositions, methods of use and treatment thereof. The present dis... |
|
|
Invention
|
Melanocortin ligands and methods of use thereof. 2, W, X, Y and Z are as defined herein, as well ... |
|
2016
|
Invention
|
Polyamine sulfonamides and uses thereof. Cancer is a disease for which there remains a great unme... |
|
|
Invention
|
Protein acyl transferase inhibitors and methods of treatment. Embodiments of the present disclosu... |
|
|
Invention
|
High-affinity small molecule formylpeptide receptor ligands from screening of combinatorial mixtu... |
|
2015
|
Invention
|
Compounds and methods of treating neurological disorders. Embodiments of the present disclosure p... |
|
|
Invention
|
Compounds and methods of treating neurological disorders.
Embodiments of the present disclosure ... |
|
|
Invention
|
Methods and compositions for treating pain. Methods and compositions for treating pain are disclo... |
|
2014
|
Invention
|
Novel opioid compounds and their uses. The present invention relates to opioid compounds, especia... |
|
2011
|
Invention
|
Env trimer immunogens.
Embodiments of the present invention are drawn to pure forms of human or ... |
|
|
Invention
|
Env trimer immunogens. Embodiments of the present invention are drawn to pure forms of human or s... |
|
2009
|
Invention
|
Methods for treating cachexia and lymphopenia.
Disappearance of a cell population, designated CD... |
|
|
Invention
|
Method of screening for metabolite transport modifiers. Methods for discovering compounds that mo... |
|
2007
|
Invention
|
Cancer vaccines and vaccination methods. Methods and compositions for treating cancers (e.g., neu... |
|
|
Invention
|
Cancer vaccines and vaccination methods. Methods and compositions for treating cancers (e g , neu... |
|
|
Invention
|
Diagnostic markers for ischemia. This invention relates to the diagnosis and monitoring of ischem... |
|
|
Invention
|
Protease screening methods and proteases identified thereby. Methods for identifying modified pro... |
|
|
Invention
|
Treatment of autoimmune disorders.
Disclosed herein are methods for the treatment of autoimmune ... |
|
|
Invention
|
Treatment of autoimmune disorders. Disclosed herein are methods for the treatment of autoimmune o... |
|
2006
|
Invention
|
Methods and compositions for derepression of iap-inhibited caspase. The invention provides isolat... |
|
|
Invention
|
Sulfatides for treatment of autoimmune disorders. Disclosed herein are methods for the treatment ... |
|
|
Invention
|
Volatilizable solid phase supports for compound synthesis. A solid phase synthetic method is disc... |
|
|
Invention
|
Inhibiting furin with polybasic peptides. i against furin of 40 nM. Non-acetylated, poly-D-argini... |
|
|
Invention
|
Methods and compositions for derepression of iap-inhibited caspase.
The invention provides isola... |
